Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer (PELICAN)

Clinical Trial ID NCT03515798

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03515798

Top papers